Montelukast, or Montelukast Sodium, works for the prophylaxis and long-term treatment of asthma, is good for preventing exercise-induced bronchoconstriction, and can be used for allergic rhinitis.
Montelukast Sodium is available in tablets (for adults aged 15 years and above), granules (for children aged 1 year and above), and chewable tablets (for children aged 2-14 years).
1. Action: For the prevention and long-term treatment of asthma. Including the prevention of daytime and nighttime asthma attacks, the treatment of asthma patients sensitive to aspirin and the prevention of exercise-induced bronchoconstriction. It is used to reduce symptoms caused by allergic rhinitis, as well as seasonal allergic rhinitis and perennial allergic rhinitis.
2. Mechanism: Montelukast is a leukotriene receptor antagonist. Montelukast can effectively inhibit the physiological effects of LTC4, LTD4 and LTE4 binding to CysLT1 receptor without any receptor agonist activity.
3. Contraindications and adverse reactions: Monteleukast is contraindicated in people who are allergic to Monteleukast. Monteleukast can cause nausea, vomiting and other adverse reactions when taken orally, but the symptoms are usually mild.
Please follow the doctor’s instructions, do not use the drug without authorization.